KYMR financials
Kymera Therapeutics (KYMR) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
KYMR income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $39.20M | $39.20M | -$349.40M | -$311.40M | -3.69 |
| 2024 | $47.07M | $47.07M | -$261.63M | -$223.86M | -2.98 |
| 2023 | $78.59M | $78.59M | -$165.53M | -$146.96M | -2.52 |
| 2022 | $46.83M | $46.83M | -$161.26M | -$154.81M | -2.87 |
| 2021 | $72.83M | $72.83M | -$100.53M | -$100.22M | -2.09 |
| 2020 | $34.03M | $34.03M | -$46.30M | -$45.59M | -0.99 |
- KYMR revenue was $39.20M in fiscal 2025, net income -$311.40M.
Updated 2026-11-07 11:56 UTC